您的位置: 首页 > 农业专利 > 详情页

APPLICATIONS DE LA KÉLIMYCINE DANS LA RÉSISTANCE À L'INFECTION PAR MYCOBACTERIUM TUBERCULOSIS
专利权人:
Shenyang Fuyang Pharmaceutical Technology Co.; Ltd.
发明人:
申请号:
EP16880885.5
公开号:
EP3384915A1
申请日:
2016.12.05
申请国别(地区):
EP
年份:
2018
代理人:
摘要:
Use of carrimycin in mycobacterium tuberculosis infection resistance comprises the main steps: measuring the activity of carrimycin in mycobacterium tuberculosis resistance by adopting an absolute concentration method through taking clinical first-line antituberculotics, i.e., isoniazid and rifampicin as controls. The result indicates that carrimycin has obvious superior activity to clinically-separated mycobacterium tuberculosis including drug-resistant bacteria compared with those of the clinical first-line control drugs, i.e., the isoniazid and the rifampicin, and use of carrimycin in manufacturing drugs for treating tubercle bacillus infected diseases are expected to be developed.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充